Sunday, June 23, 2024
HomeNanotechnologySynergistic exercise of gold nanoparticles with amphotericin B on persister cells of...

Synergistic exercise of gold nanoparticles with amphotericin B on persister cells of Candida tropicalis biofilms | Journal of Nanobiotechnology


  • WHO fungal. Precedence pathogens record to information analysis, improvement and public well being motion. Geneva: World Well being Group; 2022.


    Google Scholar
     

  • Dos Santos MM, Ishida Ok. We have to discuss Candida tropicalis: virulence elements and survival mechanisms. Med Mycol. 2023;61(8):myad075.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Malinovská Z, Čonková E, Váczi P. Biofilm formation in medically vital Candida species. J Fungi (Basel). 2023;9(10):955.

    Article 
    PubMed 

    Google Scholar
     

  • de Souza CM, Dos Santos MM, Furlaneto-Maia L, Furlaneto MC. Adhesion and biofilm formation by the opportunistic pathogen Candida tropicalis: what do we all know? Can J Microbiol. 2023;69(6):207–18.

    Article 
    PubMed 

    Google Scholar
     

  • Defraine V, Fauvart M, Michiels J. Combating bacterial persistence: present and rising anti-persister methods and therapeutics. Drug Resist Updat. 2018;38:12–26.

    Article 
    PubMed 

    Google Scholar
     

  • Wuyts J, Van Dijck P, Holtappels M. Fungal persister cells: the premise for recalcitrant infections? PLoS Pathog. 2018;14(10):e1007301.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • da Silva MA, Baronetti JL, Páez PL, Paraje MG. Oxidative imbalance in Candida tropicalis biofilms and its relation with persister cells. Entrance Microbiol. 2021;2:598834.

    Article 

    Google Scholar
     

  • Levin-Reisman I, Brauner A, Ronin I, Balaban NQ. Epistasis between antibiotic tolerance, persistence, and resistance mutations. Proc Natl Acad Sci U S A. 2019;116(29):14734–9.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kaldalu N, Hauryliuk V, Turnbull KJ, La Mensa A, Putrinš M, Tenson T. Vitro research of persister cells. Microbiol Mol Biol Rev. 2020;84(4):e00070–20.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gow NAR, Johnson C, Berman J, et al. The significance of antimicrobial resistance in medical mycology. Nat Commun. 2022;13(1):5352.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ajetunmobi OH, Badali H, Romo JA, Ramage G, Lopez-Ribot JL. Antifungal remedy of Candida biofilms: previous, current and future. Biofilm. 2023;5:100126.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shrestha L, Fan HM, Tao HR, Huang JD. Current methods to fight biofilms utilizing antimicrobial brokers and therapeutic approaches. Pathogens. 2022;25(3):292.

    Article 

    Google Scholar
     

  • Laniado-Laborín R, Cabrales-Vargas MN. Amphotericin B: unintended effects and toxicity. Rev Iberoam Micol. 2009;26(4):223–7.

    Article 
    PubMed 

    Google Scholar
     

  • Zhou ZX, Yin XD, Zhang Y, et al. Antifungal medicine and drug-induced liver damage: a real-world examine leveraging the FDA hostile occasion reporting system database. Entrance Pharmacol. 2022;13:891336.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhang L, Hu Q, Zhang Y, Wang Y, Liu N, Liu Q. Fast inactivation of combined biofilms of Candida albicans and Candida tropicalis utilizing antibacterial photodynamic remedy: Based mostly on PAD™ plus. Heliyon e15396 (2023).

  • Marioni J, Bresolı-Obach R, Agut M, et al. On the mechanism of Candida tropicalis biofilm discount by the mixed motion of naturally-occurring anthraquinones and blue mild. PLoS ONE. 2017;12:e0181517.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nasiri Ok, Masoumi SM, Amini S, et al. Current advances in metallic nanoparticles to deal with periodontitis. J Nanobiotechnol. 2023;21(1):283.

    Article 

    Google Scholar
     

  • Lotfali E, Toreyhi H, Makhdoomi Sharabiani Ok, et al. Comparability of antifungal properties of gold, silver, and selenium nanoparticles towards amphotericin B-resistant Candida Glabrata medical isolates. Avicenna J Med Biotechnol. 2021;13:47–50.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • da Silva MA, García-Martínez JC, Páez PL, Paraje MG. Fungicidal and antibiofilm actions of gold nanoparticles on Candida tropicalis. Nanomed (Lond). 2022;17(22):1663–76.

    Article 

    Google Scholar
     

  • Liu H, Huang Z, Chen H, Zhang Y, Yu P, Hu P, Zhang X, Cao J, Zhou T. A possible technique towards medical carbapenem-resistant Enterobacteriaceae: antimicrobial exercise examine of sweetener-decorated gold nanoparticles in vitro and in vivo. J Nanobiotechnol. 2023;6(1):409.

    Article 

    Google Scholar
     

  • Paraje MG. From the magic bullet to nanotechnology: nanoantimicrobials as therapeutics to combat multidrug-resistant microorganisms. Rev Argent Microbiol. 2023;55(3):204–5.

    PubMed 

    Google Scholar
     

  • Marioni J, da SilvaMA, Cabrera JL, Nunez Montoya SC, Paraje MG. The anthraquinones rubiadin and its 1-methyl ether remoted from Heterophyllaea pustulata reduces Candida tropicalis biofilms formation. Phytomedicine. 2016;23:1321–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Quinteros MA, Galera ILD, Tolosa J, García-Martínez JC, Páez PL, Paraje MG. Novel antifungal exercise of oligostyrylbenzenes compounds on Candida tropicalis biofilms. Med Mycol. 2021;59:244–52.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kim YG, Garcia-Martinez JC, Crooks RM. Electrochemical properties of monolayer-protected au and pd nanoparticles extracted from inside dendrimer templates. Langmuir. 2005;21(12):5485–91.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Garcia-Martinez JC, Crooks RM. Extraction of au nanoparticles having slender dimension distributions from inside dendrimer templates. J Am Chem Soc. 2004;126(49):16170–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Crespo KA, Baronetti JL, Quinteros MA, Páez PL, Paraje MG. Intra- and extracellular biosynthesis and characterization of iron nanoparticles from prokaryotic microorganisms with anticoagulant exercise. Pharm Res. 2017;34:591–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Medical & Laboratory Requirements Institute. Reference technique for broth dilution antifungal susceptibility testing of yeasts: Permitted customary (4th Version). Medical & Laboratory Requirements Institute, PA, USA. (2017).

  • Pierce CG, Uppuluri P, Tristan AR, et al. A easy and reproducible 96-well plate-based technique for the formation of fungal biofilms and its utility to antifungal susceptibility testing. Nat Protoc. 2008;3:1494–500.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Azeredo J, Azevedo NF, Briandet R, et al. Essential assessment on biofilm strategies. Crit Rev Microbiol. 2017;43(3):313–51.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Thieme L, Hartung A, Tramm Ok, et al. MBEC Versus MBIC: the shortage of differentiation between biofilm decreasing and inhibitory results as a present drawback in biofilm methodology. Biol Proced On-line. 2019;21:18.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Van Dijck P, Sjollema J, Cammue BP, et al. Methodologies for in vitro and in vivo analysis of efficacy of antifungal and antibiofilm brokers and floor coatings towards fungal biofilms. Microb Cell. 2018;5(7):300–26.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Al-Dhaheri RS, Douglas LJ. Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob Brokers Chemother. 2008;52:1884–7.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • De Brucker Ok, De Cremer Ok, Cammue BP, Thevissen Ok. Protocol for dedication of the persister subpopulation in Candida albicans biofilms. Strategies Mol Biol. 2016;1333:67–72.

    Article 
    PubMed 

    Google Scholar
     

  • Lohse MB, Gulati M, Craik CS, Johnson AD, Nobile CJ. Mixture of antifungal medicine and protease inhibitors stop Candida albicans biofilm formation and disrupt mature biofilms. Entrance Microbiol. 2020;11:1027.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Schwarz P, Nikolskiy I, Bidaud A-L, Sommer F, Bange G, Dannaoui E. In Vitro synergy of isavuconazole mixed with colistin towards frequent Candida species. Entrance Cell Infect Microbiol. 2022;12:892893.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bidaud AL, Schwarz P, Herbreteau G, Dannaoui E. Strategies for the evaluation of in vitro and in vivo antifungal mixtures. J Fungi (Basel). 2021;7(2):113.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Fuentealba-Manosalva O, Mansilla M, Buelvas N, Martin-Martin A, Torres CG, López-Muñoz RA. Thoughts the curve: dose-response becoming biases the synergy scores throughout software program used for chemotherapy mixture research. Int J Mol Sci. 2023;3(11):9705.

    Article 

    Google Scholar
     

  • Di Veroli GY, Fornari C, Wang D, Mollard S, Bramhall JL, Richards FM, Jodrell DI. Combenefit: an interactive platform for the evaluation and visualization of drug mixtures. Bioinformatics. 2016;15(18):2866–8.

    Article 

    Google Scholar
     

  • Lara HH, Romero-Urbina DG, Pierce C, Lopez-Ribot JL, Arellano-Jiménez MJ, Jose-Yacaman M. Impact of silver nanoparticles on Candida albicans biofilms: an ultrastructural examine. J Nanobiotech. 2015;15:13:91.

    Article 

    Google Scholar
     

  • Caldeirão ACM, Araujo HC, Arias LS, Ramírez Carmona W, Miranda GP, Oliveira SHP, Pessan JP, Monteiro DR. Nanocarriers of miconazole or fluconazole: results on three-sspecies Candida biofilms and cytotoxic results in vitro. J Fungi (Basel) 23;7(7):500 (2021)

  • Chee E, García AJ. Biomaterial therapeutic methods for therapy of bacterial lung infections. Biofilm. 2023;5:100111.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • de Alteriis E, Maselli V, Falanga A, et al. Effectivity of gold nanoparticles coated with the antimicrobial peptide indolicidin towards biofilm formation and improvement of Candida spp. medical isolates. Infect Drug Resist. 2018;11:915–25.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Carmo PHFD, Garcia MT, Figueiredo-Godoi LMA, Lage ACP, Silva NSD, Junqueira JC. Steel nanoparticles to fight Candida albicans infections: an replace. Microorganisms. 2023;11(1):138.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wambaugh MA, Denham ST, Ayala M, Brammer B, Stonhill MA, Brown JC. Synergistic and antagonistic drug interactions within the therapy of systemic fungal infections. Elife. 2020;9:e54160.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Brauner A, Fridman O, Gefen O, Balaban NQ. Distinguishing between resistance, tolerance and persistence to antibiotic therapy. Nat Rev Microbiol. 2016;14:320–30.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Solar J, Li Z, Chu H, Guo J, Jiang G, Qi Q. Candida albicans amphotericin B-tolerant persister formation is intently associated to floor adhesion. Mycopathologia. 2016;181(1–2):41–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Vazquez-Munoz R, Lopez FD, Lopez-Ribot JL. Silver nanoantibiotics show robust antifungal exercise towards the emergent multidrug-resistant yeast Candida Auris below each planktonic and biofilm rising circumstances. Entrance Microbiol. 2020;11:1673.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Okkeh M, Bloise N, Restivo E, De Vita L, Pallavicini P, Visai L. Gold nanoparticles: can they be the subsequent magic bullet for multidrug-resistant micro organism? Nanomaterials (Basel). 2021;11(2):312.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Baptista PV, McCusker MP, Carvalho A, et al. Nano-strategies to combat multidrug resistant bacteria-A battle of the titans. Entrance Microbiol. 2018;9:1441.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cavassin FB, Baú-Carneiro JL, Vilas-Boas RR, Queiroz-Telles F. Sixty years of amphotericin B: an outline of the primary antifungal agent used to deal with invasive fungal infections. Infect Dis Ther 10(1), 115–47.

  • Díaz de León-Ortega R, D’Arcy DM, Fotaki N. In vitro circumstances for efficiency analysis of merchandise for intravascular administration: growing applicable take a look at media utilizing amphotericin B as a mannequin drug. Eur J Pharm Sci. 2020;143:105174.

    Article 
    PubMed 

    Google Scholar
     

  • Manosroi A, Kongkaneramit L, Manosroi J. Stability and transdermal absorption of topical amphotericin B liposome formulations. Int J Pharm. 2004;270(1–2):279–86.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Faustino C, Serafim C, Ferreira I, Pinheiro L, Calado A. Solubilization energy of an amino acid-based gemini surfactant in the direction of the hydrophobic drug amphotericin B. Colloids Surf Physicochem Eng Asp. 2015;480:426–32.

    Article 
    CAS 

    Google Scholar
     

  • Te Dorsthorst DT, Verweij PE, Meletiadis J, Bergervoet M, Punt NC, Meis JF, Mouton JW. In vitro interplay of flucytosine mixed with amphotericin B or fluconazole towards thirty-five yeast isolates decided by each the fractional inhibitory focus index and the response floor method. Antimicrob Brokers Chemother. 2002;46(9):2982–9.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Weis MR, Levine HB. Inactivation of amphotericin B by decreasing brokers: influences on progress inhibition of Candida albicans and lysis of erythrocytes. Med Mycol. 1972;10(2):132–42.

    Article 
    CAS 

    Google Scholar
     

  • RELATED ARTICLES

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Most Popular

    Recent Comments